Confirmatory phase III trial of dasiglucagon in severe hypoglycemia meets primary endpoint May 14, 2019
Avotres opens enrollment in phase I/II trial of dendritic cell therapy AVT-001 for type 1 diabetes May 13, 2019
RSS